DEBANJAN RAY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DEBANJAN RAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DEBANJAN RAY. DEBANJAN RAY is a Chief Financial Officer in CytomX Therapeutics, Inc. ($CTMX).
Address: C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., SUITE 400 SOUTH SAN FRANCISCO 94080 CA
Companies in which DEBANJAN RAY is an Insider
CytomX Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DEBANJAN RAY: Chief Financial Officer
Holdings: 8,928 shares
Current Value: $102,672
Latest Transaction: Jan 29 2019
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DEBANJAN RAY
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29 2019 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | A | 16.85 | 90,000 | 1,516,500 | 90,000 | |
| Dec 14 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.45 | 3,000 | 4,347 | 7,220 | |
| Dec 14 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 15.00 | 3,000 | 45,000 | 5,928 | 8.9 K to 5.9 K (-33.60 %) |
| Dec 14 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.45 | 3,000 | 4,347 | 8,928 | 5.9 K to 8.9 K (+50.61 %) |
| Oct 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.45 | 3,000 | 4,347 | 13,220 | |
| Oct 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 18.46 | 3,000 | 55,380 | 5,928 | 8.9 K to 5.9 K (-33.60 %) |
| Oct 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.45 | 3,000 | 4,347 | 8,928 | 5.9 K to 8.9 K (+50.61 %) |